Article
A novel HIF2A mutation causes dyslipidemia and promotes hepatic lipid accumulation.
Pharmacological research - 1 Aug 2023
Gao Feiqiong, Yao Qigu, Zhu Jiaqi, Chen Wenyi, Feng Xudong, Feng Bing, Wu Jian, Pacak Karel, Rosenblum Jared, Yu Jiong, Zhuang Zhengping, Cao Hongcui, Li Lanjuan
Abstract excerpt
Hypoxia-inducible factor-2α (HIF-2α) is a transcription factor responsible for regulating genes related to angiogenesis and metabolism. This study aims to explore the effect of a previously unreported mutation c.C2473T (p.R825S) in the C-terminal transactivation domain (CTAD) of HIF-2α that we detected in tissue of patients with liver disease. We sequenced available liver and matched blood samples obtained during...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
